The mixed, counterintuitive results hinder trial interpretation, but along with ARREST-AF, experts still see actionable ...
In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...
One is an siRNA biologic, the other an oral agent, but both lowered Lp(a) levels by 80% or more in ASCVD patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback